Publication | Open Access
Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation
113
Citations
40
References
2021
Year
Thus, we developed a therapeutic strategy for COVID-19 based on inhalation of a modified siRNA-peptide dendrimer formulation. The developed medication is intended for inhalation treatment of COVID-19 patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1